CSF biomarkers in different phenotypes of Parkinson disease

Biomarkers in Alzheimer’s Disease

(2011) Mario Riverol et al.   Frontiers in Neurology

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

(2010) Hans Brunnström et al.   Alzheimers & Dementia

CSF markers of neurodegeneration in Parkinson’s disease

(2010) Hana Přikrylová Vranová et al.   JOURNAL OF NEURAL TRANSMISSION

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurochemical biomarkers in the differential diagnosis of movement disorders

(2010) Kurt A. Jellinger   MOVEMENT DISORDERS

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease

(2010) James B. Leverenz et al.   PARKINSONISM & RELATED DISORDERS

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease

(2009) Yaroslau Compta et al.   MOVEMENT DISORDERS

Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

(2008) Lucilla Parnetti et al.   BIOLOGICAL PSYCHIATRY